Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.

City of Hope Medical Center

14 clinical trials · 14 recruiting · OTHER

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

Trials by City of Hope Medical Center

RECRUITINGPhase 2NCT06042569

Dose-Reduced Docetaxel With Cyclophosphamide for the Treatment of Vulnerable Older Women With Stage I-III HER2 Negative...

This phase II trial tests how well dose-reduced docetaxel combined with cyclophosphamide works in treating older women with early stage (stage I-III) HER2 negative breast cancer...

Sponsor: City of Hope Medical CenterEnrolling: 1742 locations
Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage II Breast Cancer AJCC v8Anatomic Stage III Breast Cancer AJCC v8+1
RECRUITINGPhase 2NCT06528990

Telehealth Intervention for Ostomy Self-Management

Over one million individuals in the U.S. have ostomies. An ostomy is a surgical procedure that creates an opening in the abdominal wall that allows bodily waste (urinary or fecal)...

Sponsor: City of Hope Medical CenterEnrolling: 1501 location
Colorectal CancerBladder Cancer
RECRUITINGPhase 1NCT06454383

Gemcitabine and Leflunomide in Patients With Advanced Unresectable Pancreatic Cancer

This phase Ib trial tests the safety, side effects, and best dose of leflunomide in combination with gemcitabine in treating patients with pancreatic cancer that may have spread...

Sponsor: City of Hope Medical CenterEnrolling: 191 location
Advanced Pancreatic AdenocarcinomaStage III Pancreatic Cancer AJCC v8Stage IV Pancreatic Cancer AJCC v8+1
RECRUITINGPhase 1NCT05227326

AOH1996 for the Treatment of Refractory Solid Tumors

This phase I trial studies the side effects and best dose of AOH1996 in treating patients with solid tumors that do not respond to treatment (refractory). AOH1996 may stop the...

Sponsor: City of Hope Medical CenterEnrolling: 922 locations
Refractory Malignant Solid NeoplasmOsteosarcomaLeiomyosarcomas+4
RECRUITINGPhase 1NCT05157971

Venetoclax and a Pediatric-Inspired Regimen for the Treatment of Newly Diagnosed B Cell Acute Lymphoblastic Leukemia

This phase I trial tests the safety, side effects, and best dose of venetoclax in combination with a pediatric-inspired chemotherapy regimen known as C10403 in treating patients...

Sponsor: City of Hope Medical CenterEnrolling: 241 location
B Acute Lymphoblastic LeukemiaPh-Like Acute Lymphoblastic Leukemia
RECRUITINGPhase 1NCT06575296

Revumenib for the Treatment of Acute Leukemia in Patients Post-Allogeneic Stem Cell Transplant

This phase I trial tests the safety, side effects, best dose and effectiveness of revumenib in treating patients with acute leukemia after allogeneic stem cell transplant....

Sponsor: City of Hope Medical CenterEnrolling: 271 location
Acute LeukemiaAcute Leukemia of Ambiguous LineageAcute Lymphoblastic Leukemia+5
RECRUITINGPhase 1NCT04510051

CAR T Cells After Lymphodepletion for the Treatment of IL13Rα2 Positive Recurrent or Refractory Brain Tumors in Children

This phase I trial investigates the side effects of chemotherapy and cellular immunotherapy in treating children with IL13Ralpha2 positive brain tumors that have come back after a...

Sponsor: City of Hope Medical CenterEnrolling: 183 locations
Malignant Brain NeoplasmRecurrent Malignant Brain NeoplasmRefractory Malignant Brain Neoplasm
RECRUITINGPhase 1NCT03975231

Dabrafenib, Trametinib, and IMRT in Treating Patients With BRAF Mutated Anaplastic Thyroid Cancer

This trial studies how well dabrafenib, trametinib, and intensity modulated radiation therapy (IMRT) work together in treating patients with BRAF mutated anaplastic thyroid...

Sponsor: City of Hope Medical CenterEnrolling: 63 locations
BRAF NP_004324.2:p.V600EBRAF V600K Mutation PresentThyroid Gland Anaplastic Carcinoma
RECRUITINGNCT05229341

Evaluation of DNA Methylation Signatures for the Diagnosis and Management of Thyroid Nodules

This clinical trial evaluates deoxyribonucleic acid (DNA) methylation signatures in diagnosing and managing thyroid nodules. The purpose of this research is to develop a new test...

Sponsor: City of Hope Medical CenterEnrolling: 14501 location
Thyroid Gland Carcinoma
RECRUITINGPhase 2NCT06440850

Vemurafenib and Cobimetinib for the Treatment of Patients With High Risk Differentiated Thyroid Carcinoma With...

This phase II trial tests how well vemurafenib and cobimetinib work in treating patients with high risk differentiated thyroid carcinoma with BRAFV600E mutation, in preparation...

Sponsor: City of Hope Medical CenterEnrolling: 211 location
Thyroid Gland Follicular CarcinomaThyroid Gland Oncocytic CarcinomaThyroid Gland Papillary Carcinoma
RECRUITINGPhase 2NCT06052826

Geriatric Assessment Guided Interventions to Accelerate Functional Recovery After CAR-T Therapy for Patients 60 Years...

This clinical trial compares the effectiveness of geriatric assessment (GA) guided interventions to accelerate functional recovery after chimeric antigen receptor T-cell (CAR-T)...

Sponsor: City of Hope Medical CenterEnrolling: 1641 location
B-Cell Non-Hodgkin LymphomaMultiple Myeloma
RECRUITINGNCT06490159

Predicting Peripheral Neuropathy of Paclitaxel for Gastric Cancer

Although advances in chemotherapy have improved the prognosis of gastric cancer patients, many patients still suffer from adverse events. Therefore, it is necessary to establish...

Sponsor: City of Hope Medical CenterEnrolling: 1501 location
Gastric CancerChemotherapy-induced Peripheral NeuropathyPaclitaxel+1
RECRUITINGEarly Phase 1NCT04380831

TBI Using IMRT and Cyclophosphamide Prior to Stem Cell Transplant for the Treatment of Severe Systemic Sclerosis

This early phase I trial studies the side effects and feasibility of total body irradiation using intensity modulation radiation therapy (IMRT) when given in combination with...

Sponsor: City of Hope Medical CenterEnrolling: 151 location
Systemic Scleroderma
RECRUITINGPhase 2NCT05672355

A Vaccine Booster (GEO-CM04S1) for the Prevention of COVID-19 in Patients With Chronic Lymphocytic Leukemia

This phase II trial compares the effect of the GEO-CM04S1 vaccine with the current standard of care vaccine in preventing COVID-19 infections in patients with chronic lymphocytic...

Sponsor: City of Hope Medical CenterEnrolling: 801 location
Chronic Lymphocytic LeukemiaCOVID-19 Infection